摘要
背景:智能纳米载体已被设计用于组织特异性靶向药物递送,持续或触发药物释放和协同药物组合的共递送以开发更安全和更有效的治疗剂。 目标:药物递送系统的进展可减少副作用,延长循环半衰期并改善药代动力学。 结果:在癌症的情况下,智能药物递送系统已经成功实现。通过考虑来自健康组织的肿瘤微环境的差异,诸如低pH值,低氧水平或基质金属蛋白酶的高酶活性,这些纳米载体可以用作智能系统。 结论:通过增强智能纳米载体的细胞内化和控制药物释放,改善了用于癌症诊断和治疗的抗癌剂的性能。在这里,我们回顾了定位,细胞内化;控制药物释放和智能药物输送系统的毒性。我们也强调智能纳米载体的刺激响应控制药物释放
关键词: 智能药物递送,刺激响应药物释放,纳米载体,靶向药物递送,智能纳米载体,靶向癌症治疗
图形摘要
Current Drug Targets
Title:Smart Drug Delivery Systems in Cancer Therapy
Volume: 19 Issue: 3
关键词: 智能药物递送,刺激响应药物释放,纳米载体,靶向药物递送,智能纳米载体,靶向癌症治疗
摘要: Background: Smart nanocarriers have been designed for tissue-specific targeted drug delivery, sustained or triggered drug release and co-delivery of synergistic drug combinations to develop safer and more efficient therapeutics.
Objective: Advances in drug delivery systems provide reduced side effects, longer circulation half-life and improved pharmacokinetics.
Results: Smart drug delivery systems have been achieved successfully in the case of cancer. These nanocarriers can serve as an intelligent system by considering the differences of tumor microenvironment from healthy tissue, such as low pH, low oxygen level, or high enzymatic activity of matrix metalloproteinases.
Conclusion: The performance of anti-cancer agents used in cancer diagnosis and therapy is improved by enhanced cellular internalization of smart nanocarriers and controlled drug release. Here, we review targeting, cellular internalization; controlled drug release and toxicity of smart drug delivery systems. We are also emphasizing the stimulus responsive controlled drug release from smart nanocarriers.
Export Options
About this article
Cite this article as:
Smart Drug Delivery Systems in Cancer Therapy, Current Drug Targets 2018; 19 (3) . https://dx.doi.org/10.2174/1389450117666160401124624
DOI https://dx.doi.org/10.2174/1389450117666160401124624 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Caspases and ROS - Dependent Mechanism of Action Mediated by Combination of WP 631 and Epothilone B
Anti-Cancer Agents in Medicinal Chemistry Another Brick in the Wall: Innate Lymphoid Cells of the Intestine
Current Immunology Reviews (Discontinued) Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER-positive Breast Cancer Therapy
Mini-Reviews in Medicinal Chemistry TRP Channels and Pain
Current Pharmaceutical Design Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
Current Pharmaceutical Biotechnology Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Anti-Cancer Agents in Medicinal Chemistry Possible Targets of Herbals for Type 3 Diabetes: A Review
Current Traditional Medicine Chlorotoxin-Conjugated Nanoparticles for Targeted Imaging and Therapy of Glioma
Current Topics in Medicinal Chemistry New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews The Epigenetic Origin of Aneuploidy
Current Genomics Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation 1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry PPARγ-targeting Potential for Radioprotection
Current Drug Targets Epigenetic Regulators Governing Cancer Stem Cells and Epithelial- Mesenchymal Transition in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion
Mini-Reviews in Medicinal Chemistry Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents
Recent Patents on Nanotechnology Advances in the Development of Multimodal Imaging Agents for Nuclear/Near-infrared Fluorescence Imaging
Current Medicinal Chemistry Chloroform Fraction of Methanolic Extract of Seeds of <i>Annona muricata</i> Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
Anti-Cancer Agents in Medicinal Chemistry